Gidi Kimchi Co-Founder, CEO
Over 25 years of experience in founding and managing software companies in the US, Europe and Israel.
Founded, led and sold one of the 10 largest IT companies in Israel (more than 700 employees and hundreds of millions in sales) and one of the top global QA and testing companies in the world. Led IPO in TASE and managed a public company for 14 years.
Since 2008, he has been investing and mentoring start up companies helping them in business development and approaching the global markets.
Gidi holds an M.B.A from Bar Ilan University, B.Sc. degree (Cum Laude) in Computers and Mathematics from Ben-Gurion University and MA in law (Cum Laude) from Netanya Academic College.
Gidi is a member (since 2003) in the YPO (a global Presidents/CEOs organization with more than 20,000 members in over 130 countries) and also participated in Harvard Business School- YPO president’s seminar.
Doron Debbie Co-Founder, Director
Over 25 years of experience in the Health Care Market (Including Consumer Health Care) representing Multinational Health Care companies with proven track record of successes.
CEO and owner of Sigma Health Care bd company since 2005 - representing innovative medical technologies of multinational companies in the Israeli market by way of sales, marketing, clinical studies and strategic investments in Israel.
In the past established and managed the Israeli subsidiary of Boston Scientific and previously he was VP Sales, Marketing and Business Development at Promedico represented in Israel exclusively global companies such as Pfizer, Abbott Lab, Novartis and many others.
Industrial engineer and MBA Tel-Aviv University and International Business Management Courses at INSEAD France.
Doron Won several reputable awards and recognitions from Multi-National Health Care companies for his contribution to their successes. Doron is on boards of directors and investment committees in several companies. On 2012 Doron has founded MaC Fund the first Israeli-Korean Venture Capital.
Dr. Izak Daizade, MD is one of the leading experts in the orthopedic surgery field. Having graduated from medical school in Tehran Iran in 1978.
Dr. Daizade completed his residency in Orthopedic surgery at Beilinson Hospital in Israel and interned in the General, Vascular, and Neurosurgery Departments as well as the ICU and Research Departments at Tel Aviv University. Dr. Daizade completed his fellowship in spinal surgery at Beilinson Hospital Petah Tiqva and served as the Chief Orthopedic Doctor at one of the country’s most prominent hospitals. At the same time, he ran several Orthopedic Surgery private clinics across the country. Dr. Daizade has developed and patented innovative orthopedic products all around the world since 2007. Dr. Daizade founded UNFO Med Ltd. in order to continue developing innovative treatments for newborns afflicted with congenital foot deformities.
Yossi BenAmram Co-Founder
Yossi BenAmam is a seasoned executive and an expert in the global pharma industry. With over 30 years of proven track record for achieving sustainable leveraged growth through shaping compelling vision, fostering customer and patient focus, shaping the environment, driving access to innovation, collaborating with commercial partners, demonstrating operational excellence, champion digital transformation and building strong and diverse teams.
In Mar 2019 Yossi co-founded and is serving as the CEO of MediCane Health Inc. a fully integrated global pharmaceutical company that intends to provide broad access to innovative and high quality medical and pharmaceutical cannabis medications to patients in need around the globe.
From mid-2016 until Feb 2019 Yossi served as Senior Vice President and President of EURAM (Europe, Russia, Africa and Middle East) region for Merck & Co., Inc. (known as MSD outside the U.S. and Canada). Yossi successfully led a $4B business covering more than 100 countries. From August of 2013 until May 2016 Yossi has served as a Senior Vice President and as President of Merck’s Diversified Brands Customer Business Line (CBL). Yossi was tasked with P&L responsibility for Merck’s multi-billion USD off-patent originals portfolio of products spanning more than 10 different therapy areas and operational hubs in NJ-USA, Lucerne-Switzerland and Shanghai-China.
From August 2010 until August 2013, Yossi BenAmram served as Vice President and General Manager of Emerging Market (EM) operations. Yossi's team was tasked with the development of the EM strategy, Commercial Innovation initiatives and sales & marketing capability building. From October 2007 until July 2010, Yossi served as a Vice President and Global Brand Leader for Respiratory products including the blockbusters SINGULAIRÒ and NASONEXÒ and between 2000 -2007 served and the Managing Director of MSD in Israel.
Prior to joining Merck in 1998, Yossi held several positions at TEVA Pharmaceuticals. He holds an MBA and a B.A. in Economics and Management from the Recanati Graduate School of Business Administration, Tel Aviv University, Tel Aviv, Israel.
Dr. Izak Daizade, MD - UNFO Inventor, Senior Advisor